Kinglassie (GB)
{name}
{subtitle}
Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)
city
~21 mi. (Edinburgh, United Kingdom, +226 more cities)
facility
Western General Hospital ( Site 0531)
condition
Prostate Adenocarcinoma
drug
enzalutamide, +1 more drug
drug type
hormone therapy, +1 more type
Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin Plus Cystectomy Versus Cystectomy Alone in Cisplatin-ineligible Participants With Muscle-invasive Bladder Cancer (MK-3475-905/KEYNOTE-905/EV-303)
city
~21 mi. (Edinburgh, United Kingdom, +163 more cities)
facility
Western General Hospital ( Site 0749)
condition
Bladder Urothelial Carcinoma
drug
cystectomy, +2 more drugs
drug type
chemotherapy, +3 more types
Substudy 03A: A Study of Immune and Targeted Combination Therapies in Participants With First Line (1L) Renal Cell Carcinoma (MK-3475-03A)
city
~21 mi. (Edinburgh, United Kingdom, +27 more cities)
facility
Western General Hospital ( Site 1402)
condition
Clear Cell Renal Cell Carcinoma
drug
belzutifan, +4 more drugs
drug type
immunotherapy, +1 more type
Substudy 03B: A Study of Immune and Targeted Combination Therapies in Participants With Second Line Plus (2L+) Renal Cell Carcinoma (MK-3475-03B)
city
~21 mi. (Edinburgh, United Kingdom, +28 more cities)
facility
Western General Hospital ( Site 3402)
condition
Clear Cell Renal Cell Carcinoma
drug
belzutifan, +5 more drugs
drug type
immunotherapy, +1 more type
Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)
city
~31 mi. (Dundee, United Kingdom, +122 more cities)
facility
Ninewells Hospital and Medical School ( Site 2401)
condition
Small Cell Lung Carcinoma
drug
etoposide, +5 more drugs
drug type
chemotherapy, +3 more types
Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
city
~48 mi. (Airdrie, United Kingdom, +141 more cities)
facility
GSK Investigational Site
condition
Multiple Myeloma
drug
belantamab mafodotin
drug type
chemotherapy, +1 more type
Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)
city
~60 mi. (Glasgow, United Kingdom, +176 more cities)
facility
Beatson West of Scotland Cancer Centre ( Site 2247)
condition
Endometrial Carcinoma, +1 more condition
drug
chemotherapy, +2 more drugs
drug type
chemotherapy, +2 more types
Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)
city
~60 mi. (Glasgow, United Kingdom, +199 more cities)
facility
The Beatson West of Scotland Cancer Centre ( Site 0750)
condition
Hepatocellular Carcinoma
drug
pembrolizumab
drug type
immunotherapy
A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML)
city
~60 mi. (Glasgow, United Kingdom, +127 more cities)
facility
NHS Greater Glasgow and Clyde /ID# 215663
condition
Acute Myeloid Leukemia
drug
azacitidine, +2 more drugs
drug type
chemotherapy